New combo therapy aims to tame tough pancreatic tumors

NCT ID NCT07157033

First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 20 times

Summary

This early-stage study tests a drug called XER-001 given through a tube into the small intestine, combined with precise radiation, for people with locally advanced pancreatic cancer. The goal is to find the safest dose and see if the treatment can control the tumor. About 36 adults with this type of cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CIty of Hope

    RECRUITING

    Irvine, California, 92618, United States

    Contact

    Contact Email: •••••@•••••

  • Christus St. Vincent Regional Cancer Center

    RECRUITING

    Santa Fe, New Mexico, 87505, United States

    Contact

    Contact Email: •••••@•••••

  • City of Hope

    RECRUITING

    Duarte, California, 91010, United States

    Contact Email: •••••@•••••

    Contact

  • Oncology Consultants, P.A.

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.